-

Kit Check Announces New Sanitization Feature and Medication Tagging Milestone

Company’s RFID solution, now with Sanitization Check feature to better support COVID-19 frontline providers, reaches 100 million medications tagged

WASHINGTON--(BUSINESS WIRE)--Kit Check™, the leader in automated and intelligent medication management solutions, today announced that on the heels of tracking its 100 millionth dose – at OhioHealth Grant Hospital with a 10 ml vial of Sodium Chloride 0.9% – via its RFID-enabled, cloud-based platform, a new feature is now available: Sanitization Check. This feature was created due to the heightened need for infection control protocols amidst the COVID-19 pandemic and will help frontline providers and medical organizations avoid spreading contamination via medication trays.

“We’re committed to doing anything we can to help healthcare workers on the frontlines, and we’re incredibly grateful for the work our customers are doing,” said Jennifer Symon, R.Ph., MBA, FACHE and director of clinical solutions at Kit Check. “From the start, our primary concern has been protecting patients from harm, which has driven our mission to help hospitals track medications and monitor for potential drug diversions and medication shortages. Now, with the addition of Sanitization Check, we’ve expanded our protective efforts to include doing our part to mitigate the transmission of disease.”

Sanitization Check serves as an enhancement to customers’ existing systems and is a feature that hospitals can activate during the dispatch of kits and trays. If Sanitization Check is turned on, a checkbox appears that allows pharmacists or technicians to indicate whether a tray has been sanitized. Hospitals can decide whether to make the setting optional or required, and if required, the system will not allow the tray to be dispatched unless the sanitization box has been checked. More than 20 hospitals, many in hot spots like Washington and California, are already using the new feature.

“As our customers continue to feel the impact of COVID-19, we’re committed to listening to their needs and providing agile solutions such as ensuring medication trays are cleaned and sterilized,” said Kevin MacDonald, Kit Check co-founder and CEO. “Our RFID technology has proven to be scalable, precise, and quick for tracking hospital medications and restocking pharmacy kits, and with 100 million medications tracked at more than 500 hospitals, we are proud to be recognized by hospital pharmacy directors as a reliable and time-saving solution to a tedious process.”

The traditionally manual process of kit and tray restocking is time-consuming and prone to human error. Hospitals that have automated this process have seen a time savings of nearly 80 percent. Instead of 30 minutes of manual labor, Kit Check’s software reduces these processes to just a few minutes, a savings that adds up to 2.5 days per month in staff time that can be shifted to improving patient safety and clinical care outcomes. In addition, Kit Check’s solutions can help detect drug diversion in hospitals and can help them best prepare for shortages. Kit Check recently released its 4th annual Hospital Pharmacy Operations Report touching on these issues and other challenges hospital pharmacies are facing – the full report can be found here.

To learn more about Kit Check’s solutions, please visit www.kitcheck.com.

About Kit Check™

Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking medication intelligence platforms provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 500 U.S. and Canadian hospital partners have tracked more than 100 million medications using Kit Check’s RFID product. Bluesight™ for Controlled Substances software is currently in use in more than 100 hospitals including full health system implementations, with nearly 9 million cases tracked, and was ranked #1 in the Drug Diversion Monitoring category in the 2019 Best in KLAS report. More information about Kit Check and our software solutions can be found at kitcheck.com.

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com

Kit Check


Release Summary
Kit Check today announced that on the heels of tracking its 100 millionth dose, a new feature is now available: Sanitization Check.
Release Versions

Contacts

Jill Gross
Matter Health for Kit Check
kitcheck@matternow.com

More News From Kit Check

New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management

ALEXANDRIA, Va.--(BUSINESS WIRE)--BluesightⓇ, The Medication Intelligence™ Company, today published the results of a recent survey measuring U.S. consumers’ trust in the U.S. healthcare system and pharmaceutical industry, which revealed that trust in both is below average. The study also explored how prior knowledge about drug diversion – among other factors – may impact patient perception and decisions about where to seek care. “Through our suite of software solutions, Bluesight aims to provid...

Medication Intelligence Leader Kit CheckⓇ Rebrands as BluesightⓇ

LAS VEGAS--(BUSINESS WIRE)--Kit Check today announced that it has rebranded as BluesightⓇ, The Medication Intelligence™ Company, to reflect its comprehensive suite of software solutions, maintaining its commitment to helping hospitals better serve their patients and pursuing a future where the medication supply chain is more efficient and connected. Founded in 2011, Bluesight provides unit-level visibility of pharmaceutical products from manufacturing plant to patient, addressing challenges suc...

Kit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes

ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health sy...
Back to Newsroom